Suppr超能文献

神经纤维瘤病 2 型患者的人工耳蜗植入听觉康复。

Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.

机构信息

Department of Otolaryngology, New York University School of Medicine, New York, New York 10016, USA.

出版信息

J Neurosurg. 2011 Oct;115(4):827-34. doi: 10.3171/2011.5.JNS101929. Epub 2011 Jul 15.

Abstract

OBJECT

The aim of this study was to determine whether patients with neurofibromatosis Type 2 (NF2) who have intact ipsilateral cochlear nerves can have open-set speech discrimination following cochlear implantation.

METHODS

Records of 7 patients with documented NF2 were reviewed to determine speech discrimination outcomes following cochlear implantation. Outcomes were measured using consonant-nucleus-consonant words and phonemes; Hearing in Noise Test sentences in quiet; and City University of New York sentences in quiet and in noise.

RESULTS

Preoperatively, none of the patients had open-set speech discrimination. Five of the 7 patients had previously undergone excision of ipsilateral vestibular schwannoma (VS). One of the patients who received a cochlear implant had received radiation therapy for ipsilateral VS, and another was undergoing observation for a small ipsilateral VS. Following cochlear implantation, 4 of 7 patients with NF2 had open-set speech discrimination following cochlear implantation during extended follow-up (15-120 months). Two of the 3 patients without open-set speech understanding had a prolonged period between ipsilateral VS resection and cochlear implantation (120 and 132 months), and had cochlear ossification at the time of implantation. The other patient without open-set speech understanding had good contralateral hearing at the time of cochlear implantation. Despite these findings, 6 of the 7 patients were daily users of their cochlear implants, and the seventh is an occasional user, indicating that all of the patients subjectively gained some benefit from their implants.

CONCLUSIONS

Cochlear implantation can provide long-term auditory rehabilitation, with open-set speech discrimination for patients with NF2 who have intact ipsilateral cochlear nerves. Factors that can affect implant performance include the following: 1) a prolonged time between VS resection and implantation; and 2) cochlear ossification.

摘要

目的

本研究旨在确定是否存在神经纤维瘤病 2 型(NF2)且同侧耳蜗神经完整的患者,在接受耳蜗植入后能否实现开放式言语辨别。

方法

回顾了 7 例经证实的 NF2 患者的病历,以确定其耳蜗植入后的言语辨别结果。使用辅音-核-辅音词和音素来测量结果;在安静环境下使用 Hearing in Noise Test 句子;在安静和嘈杂环境下使用 City University of New York 句子。

结果

术前,没有患者具有开放式言语辨别能力。7 例患者中有 5 例曾行同侧前庭神经鞘瘤(VS)切除术。其中一位接受耳蜗植入的患者曾接受同侧 VS 放射治疗,另一位患者因同侧小 VS 而接受观察。在接受耳蜗植入后,7 例 NF2 患者中有 4 例在延长随访(15-120 个月)期间实现了开放式言语辨别。3 例未实现开放式言语理解的患者中有 2 例(120 和 132 个月)同侧 VS 切除与耳蜗植入之间的时间间隔较长,且在植入时存在耳蜗骨化。另一位未实现开放式言语理解的患者在植入时具有良好的对侧听力。尽管存在这些发现,7 例患者中有 6 例是耳蜗植入的日常使用者,第 7 例是偶尔使用者,这表明所有患者都从植入物中获得了一些主观收益。

结论

对于同侧耳蜗神经完整的 NF2 患者,耳蜗植入可以提供长期的听觉康复,并实现开放式言语辨别。影响植入物性能的因素包括:1)VS 切除与植入之间的时间延长;2)耳蜗骨化。

相似文献

1
Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.
J Neurosurg. 2011 Oct;115(4):827-34. doi: 10.3171/2011.5.JNS101929. Epub 2011 Jul 15.
2
Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
Cochlear Implants Int. 2016 Jul;17(4):172-177. doi: 10.1080/14670100.2016.1197587.
3
Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
Otol Neurotol. 2012 Jul;33(5):853-62. doi: 10.1097/MAO.0b013e318254fba5.
5
Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Otol Neurotol. 2006 Jun;27(4):512-8. doi: 10.1097/01.mao.0000217351.86925.51.
6
Cochlear implantation after radiosurgery for vestibular schwannoma.
J Neurosurg. 2021 Jul 1;135(1):126-135. doi: 10.3171/2020.4.JNS201069. Epub 2021 Jun 24.
7
Cochlear Implant Outcomes between Patients with Sporadic and Neurofibromatosis Type 2-Associated Vestibular Schwannoma.
Otol Neurotol. 2023 Sep 1;44(8):791-797. doi: 10.1097/MAO.0000000000003963. Epub 2023 Jul 18.
8
Efficacy of Cochlear Implantation in Neurofibromatosis Type 2 Related Hearing Loss.
Ann Otol Rhinol Laryngol. 2023 Mar;132(3):284-293. doi: 10.1177/00034894221091010. Epub 2022 Apr 21.

引用本文的文献

1
Longitudinal Performance of Cochlear Implants in Neurofibromatosis Type 2.
Laryngoscope. 2024 Apr;134(4):1847-1853. doi: 10.1002/lary.31044. Epub 2023 Sep 12.
2
Treated large posterior fossa vestibular schwannoma and meningioma: Hearing outcome and willingness-to-accept brain implant for unilateral deafness.
Laryngoscope Investig Otolaryngol. 2022 Oct 27;7(6):2057-2063. doi: 10.1002/lio2.957. eCollection 2022 Dec.
3
Cochlear implant in vestibular schwannomas: long-term outcomes and critical analysis of indications.
Eur Arch Otorhinolaryngol. 2022 Oct;279(10):4709-4718. doi: 10.1007/s00405-021-07243-0. Epub 2022 Jan 12.
4
Establishment of nomograms for the prediction of useful hearing loss in patients with neurofibromatosis type 2.
J Neurooncol. 2021 Dec;155(3):373-381. doi: 10.1007/s11060-021-03889-2. Epub 2021 Nov 9.
5
Cochlear Implantation in Vestibular Schwannoma: A Systematic Literature Review.
J Neurol Surg B Skull Base. 2021 Jun 8;82(6):643-651. doi: 10.1055/s-0040-1715606. eCollection 2021 Dec.
6
Cochlear Implantation After Radiotherapy of Vestibular Schwannomas.
J Int Adv Otol. 2021 Sep;17(5):452-460. doi: 10.5152/iao.2021.21008.
7
Current Understanding of Hearing Loss in Sporadic Vestibular Schwannomas: A Systematic Review.
Front Oncol. 2021 Aug 12;11:687201. doi: 10.3389/fonc.2021.687201. eCollection 2021.
9
Cochlear Implantation in Sporadic Vestibular Schwannoma: A Systematic Literature Review.
J Neurol Surg B Skull Base. 2019 Dec;80(6):632-639. doi: 10.1055/s-0038-1676768. Epub 2019 Jan 8.
10
Auditory Brainstem Implantation: An Overview.
J Neurol Surg B Skull Base. 2019 Apr;80(2):203-208. doi: 10.1055/s-0039-1679891. Epub 2019 Feb 14.

本文引用的文献

1
Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients.
Otol Neurotol. 2010 Sep;31(7):1135-43. doi: 10.1097/MAO.0b013e3181eb328a.
2
Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.
Cancer Res. 2010 May 1;70(9):3483-93. doi: 10.1158/0008-5472.CAN-09-3107. Epub 2010 Apr 20.
3
Complications in auditory brainstem implant surgery in adults and children.
Otol Neurotol. 2010 Jun;31(4):558-64. doi: 10.1097/MAO.0b013e3181db7055.
4
Cochlear implantation in neurofibromatosis type 2 after radiation therapy.
Otol Neurotol. 2010 Feb;31(2):216-9. doi: 10.1097/MAO.0b013e3181c348e7.
5
A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma.
J Neurosurg. 2010 Apr;112(4):851-9. doi: 10.3171/2009.8.JNS0985.
6
Neurofibromatosis type 2 (NF2): a clinical and molecular review.
Orphanet J Rare Dis. 2009 Jun 19;4:16. doi: 10.1186/1750-1172-4-16.
7
Neurofibromatosis type 2.
Lancet. 2009 Jun 6;373(9679):1974-86. doi: 10.1016/S0140-6736(09)60259-2. Epub 2009 May 22.
9
Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2.
Acta Otolaryngol. 2009 Sep;129(9):971-5. doi: 10.1080/00016480802510202.
10
Cochlear implantation after translabyrinthine acoustic tumour removal: preliminary results.
Cochlear Implants Int. 2005 Sep;6 Suppl 1:20-4. doi: 10.1179/cim.2005.6.Supplement-1.20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验